BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 35326605)

  • 21. Targeted cancer therapy using radiolabeled monoclonal antibodies.
    Bethge WA; Sandmaier BM
    Technol Cancer Res Treat; 2005 Aug; 4(4):393-405. PubMed ID: 16029058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
    J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Newer treatments for non-Hodgkin's lymphoma: monoclonal antibodies.
    Maloney DG; Press OW
    Oncology (Williston Park); 1998 Oct; 12(10 Suppl 8):63-76. PubMed ID: 9830635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioimmunotherapy and colorectal cancer.
    Koppe MJ; Bleichrodt RP; Oyen WJ; Boerman OC
    Br J Surg; 2005 Mar; 92(3):264-76. PubMed ID: 15739250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunotherapy for non-Hodgkin's lymphoma.
    Emmanouilides C
    Semin Oncol; 2003 Aug; 30(4):531-44. PubMed ID: 12939722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody treatment of solid tumors: a coming of age.
    Murray JL
    Semin Oncol; 2000 Dec; 27(6 Suppl 11):64-70; discussion 92-100. PubMed ID: 11236030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioimmunotherapy of B-Cell Non-Hodgkin's Lymphoma.
    Bodet-Milin C; Ferrer L; Pallardy A; Eugène T; Rauscher A; Alain Faivre-Chauvet ; Barbet J; Kraeber-Bodéré F
    Front Oncol; 2013; 3():177. PubMed ID: 23875170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioimmunotherapy for delivery of cytotoxic radioisotopes: current status and challenges.
    Martins CD; Kramer-Marek G; Oyen WJG
    Expert Opin Drug Deliv; 2018 Feb; 15(2):185-196. PubMed ID: 28893110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma.
    Postema EJ; Boerman OC; Oyen WJ; Raemaekers JM; Corstens FH
    Eur J Nucl Med; 2001 Nov; 28(11):1725-35. PubMed ID: 11702116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioimmunotherapy of malignancies.
    Reilly RM
    Clin Pharm; 1991 May; 10(5):359-75. PubMed ID: 2049898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Centralized radiolabeling of antibodies for radioimmunotherapy.
    Colcher D
    J Nucl Med; 1998 Aug; 39(8 Suppl):11S-13S. PubMed ID: 9708565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted cancer therapy and immunosuppression using radiolabeled monoclonal antibodies.
    Bethge WA; Sandmaier BM
    Semin Oncol; 2004 Feb; 31(1):68-82. PubMed ID: 14970939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma.
    Kaminski MS; Fig LM; Zasadny KR; Koral KF; DelRosario RB; Francis IR; Hanson CA; Normolle DP; Mudgett E; Liu CP
    J Clin Oncol; 1992 Nov; 10(11):1696-711. PubMed ID: 1403053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radiolabeled antibodies for cancer treatment].
    Barbet J; Chatal JF; Kraeber-Bodéré F
    Med Sci (Paris); 2009 Dec; 25(12):1039-45. PubMed ID: 20035676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental approaches to increase radiolabeled antibody localization in tumors.
    Buchsbaum DJ
    Cancer Res; 1995 Dec; 55(23 Suppl):5729s-5732s. PubMed ID: 7493336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of radioimmunotherapy using pretargeting.
    Frampas E; Rousseau C; Bodet-Milin C; Barbet J; Chatal JF; Kraeber-Bodéré F
    Front Oncol; 2013; 3():159. PubMed ID: 23802097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives on metals-based radioimmunotherapy (RIT): moving forward.
    White JM; Escorcia FE; Viola NT
    Theranostics; 2021; 11(13):6293-6314. PubMed ID: 33995659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B7-H3-targeted Radioimmunotherapy of Human Cancer.
    Kasten BB; Ferrone S; Zinn KR; Buchsbaum DJ
    Curr Med Chem; 2020; 27(24):4016-4038. PubMed ID: 30836909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioimmunotherapy: potential as a therapeutic strategy in non-Hodgkin's lymphoma.
    Wun T; Kwon DS; Tuscano JM
    BioDrugs; 2001; 15(3):151-62. PubMed ID: 11437681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioimmunotherapy of infectious diseases.
    Dadachova E; Casadevall A
    Semin Nucl Med; 2009 Mar; 39(2):146-53. PubMed ID: 19187806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.